MOS
VRTX icon

MGO One Seven’s Vertex Pharmaceuticals VRTX Stock Holding History

MGO One Seven’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.78M Buy
3,581
+316
+10% +$140K 0.03% 530
2026
Q1 		$1.46M Buy
3,265
+930
+40% +$434K 0.03% 549
2025
Q4 		$1.06M Buy
2,335
+185
+9% +$79.7K 0.02% 624
2025
Q3 		$842K Buy
2,150
+328
+18% +$137K 0.02% 638
2025
Q2 		$811K Buy
1,822
+43
+2% +$19.8K 0.03% 563
2025
Q1 		$862K Sell
1,779
-3,963
-69% -$1.85M 0.03% 471
2024
Q4 		$2.31M Buy
5,742
+2,336
+69% +$1.08M 0.09% 249
2024
Q3 		$1.58M Buy
3,406
+185
+6% +$88.9K 0.07% 289
2024
Q2 		$1.51M Buy
3,221
+1,598
+98% +$694K 0.07% 276
2024
Q1 		$678K Buy
1,623
+404
+33% +$171K 0.04% 442
2023
Q4 		$496K Buy
1,219
+406
+50% +$150K 0.03% 535
2023
Q3 		$283K Sell
813
-122
-13% -$42.7K 0.02% 638
2023
Q2 		$329K Sell
935
-377
-29% -$127K 0.03% 563
2023
Q1 		$413K Buy
1,312
+109
+9% +$32.7K 0.03% 538
2022
Q4 		$347K Buy
1,203
+234
+24% +$71.3K 0.03% 508
2022
Q3 		$519 Buy
969
+82
+9% +$23.6K 0.02% 381
2022
Q2 		$250K Sell
887
-75
-8% -$20.1K 0.03% 517
2022
Q1 		$251K Buy
+962
New +$228K 0.03% 555
2019
Q1 		– Sell
-195
Closed -$32K – 1614
2018
Q4 		$32K Buy
+195
New +$33.8K 0.01% 769
2018
Q1 		$33K Sell
201
-4
-2% -$653 0.02% 722
2017
Q4 		$31K Buy
+205
New +$30.4K 0.01% 751

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

MGO One Seven's VRTX Position: Q2 2026 in Review

MGO One Seven increased its Vertex Pharmaceuticals (VRTX) stake by 9.7% in Q2 2026, buying an estimated $140K and bringing the position to 3,581 shares worth $1.78M. The position accounts for 0.03% of the portfolio, ranked #530.

MGO One Seven first reported a position in VRTX in Q4 2017 and has held it in 21 quarters since. The position peaked at $2.31M in Q4 2024. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • MGO One Seven held 3,581 shares of Vertex Pharmaceuticals worth $1.78M as of Q2 2026.
  • MGO One Seven bought 316 Vertex Pharmaceuticals shares in Q2 2026, an estimated $140K.
  • Vertex Pharmaceuticals made up 0.03% of MGO One Seven's portfolio in Q2 2026, its #530 holding.
  • MGO One Seven first reported a position in Vertex Pharmaceuticals in Q4 2017 and has held it in 21 quarters since.
  • MGO One Seven's Vertex Pharmaceuticals position peaked at $2.31M in Q4 2024.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on MGO One Seven's 13F filing for Q2 2026, filed 31 Jul 2026.